Please assess the completion status of the following clinical trial:

Trial Title: Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
INCLUSION CRITERIA:~* Provide informed consent~* Age ≥ 18 years and of either sex~* Willing to comply with protocol instructions, including allowing all study assessments~* Have a Venous Leg Ulcer (VLU) between the knee and ankle (at or above the malleolus), with a surface area ≥ 2.0 cm2 and ≤ 36.0 cm2~* Target ulcer duration ≥ 4 weeks but ≤ 104 weeks (24 months)~* Have a Diabetic Foot Ulcer (DFU) present on any part of the plantar or dorsum surface of the foot, with a surface area ≥ 0.5 cm2 and ≤ 10.0 cm2~* Target ulcer involves a full thickness skin loss, but WITHOUT exposure of tendon, muscle, or bone~* Target ulcer duration ≥ 4 weeks but ≤ 52 weeks (12 months)~* Acceptable state of health and nutrition~EXCLUSION CRITERIA~* Therapy with another investigational agent within thirty (30) days of Screening, or during the study Ulcers which are deemed as highly exuding, per the Investigator's discretion.~* Current diagnosis of osteomyelitis at the target wound location that is not currently receiving treatment \[Documented history of resolved osteomyelitis is allowed\].~* Subjects with a VLU: Refusal of or inability to tolerate compression therapy.~* Clinical evidence of target ulcer infection~* Current systemic therapy with cytotoxic drugs.~* Current therapy with chronic (\> 10 days) oral corticosteroids.~* Previous treatment with NPWT device or hyperbaric oxygen within 7 days of screening.~* Malignancy in the target ulcer, or history of cancer in the preceding 5 years (other than carcinoma in situ of the cervix or adequately treated non-melanoma skin cancers)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PICO System (Type: EXPERIMENTAL): Negative Pressure Wound Therapy (NPWT) at 80mmHg (nominal) +/- 20 mmHg to the wound surface
- tNPWT System (Type: ACTIVE_COMPARATOR): Traditional NPWT (tNPWT) from -25 mmHg and up to -200 mmHg; intensity settings of either low, medium and high; delivery modes of continuous or intermittent. The pressure, intensity and delivery settings will be left to the Investigator's discretion at each study treatment visit.

Based on this trial design, predict the completion outcome and termination type (if applicable).